127 related articles for article (PubMed ID: 15929076)
1. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.
Zhao M; Rosenbaum E; Carvalho AL; Koch W; Jiang W; Sidransky D; Califano J
Int J Cancer; 2005 Nov; 117(4):605-10. PubMed ID: 15929076
[TBL] [Abstract][Full Text] [Related]
2. Increased mitochondrial DNA content in saliva associated with head and neck cancer.
Jiang WW; Masayesva B; Zahurak M; Carvalho AL; Rosenbaum E; Mambo E; Zhou S; Minhas K; Benoit N; Westra WH; Alberg A; Sidransky D; Koch W; Califano J
Clin Cancer Res; 2005 Apr; 11(7):2486-91. PubMed ID: 15814624
[TBL] [Abstract][Full Text] [Related]
3. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.
Chuang AY; Chuang TC; Chang S; Zhou S; Begum S; Westra WH; Ha PK; Koch WM; Califano JA
Oral Oncol; 2008 Oct; 44(10):915-9. PubMed ID: 18329326
[TBL] [Abstract][Full Text] [Related]
4. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.
Capone RB; Pai SI; Koch WM; Gillison ML; Danish HN; Westra WH; Daniel R; Shah KV; Sidransky D
Clin Cancer Res; 2000 Nov; 6(11):4171-5. PubMed ID: 11106228
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck.
Koskinen WJ; Chen RW; Leivo I; Mäkitie A; Bäck L; Kontio R; Suuronen R; Lindqvist C; Auvinen E; Molijn A; Quint WG; Vaheri A; Aaltonen LM
Int J Cancer; 2003 Nov; 107(3):401-6. PubMed ID: 14506740
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
8. [Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].
Szentirmay Z; Szántó I; Bálint I; Pólus K; Remenár E; Tamás L; Szentkúti G; Melegh Z; Nagy P; Kásler M
Magy Onkol; 2002; 46(1):35-41. PubMed ID: 12050680
[TBL] [Abstract][Full Text] [Related]
9. HPV detection rate in saliva may depend on the immune system efficiency.
Adamopoulou M; Vairaktaris E; Panis V; Nkenke E; Neukam FW; Yapijakis C
In Vivo; 2008; 22(5):599-602. PubMed ID: 18853753
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.
D'Souza G; Sugar E; Ruby W; Gravitt P; Gillison M
J Clin Microbiol; 2005 Nov; 43(11):5526-35. PubMed ID: 16272481
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland.
Anderson CE; McLaren KM; Rae F; Sanderson RJ; Cuschieri KS
J Clin Pathol; 2007 Apr; 60(4):439-41. PubMed ID: 17405984
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma.
Mineta H; Ogino T; Amano HM; Ohkawa Y; Araki K; Takebayashi S; Miura K
Anticancer Res; 1998; 18(6B):4765-8. PubMed ID: 9891554
[TBL] [Abstract][Full Text] [Related]
13. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and Epstein-Barr virus in epithelial carcinomas of the head and neck region.
Atula S; Auvinen E; Grenman R; Syrjänen S
Anticancer Res; 1997; 17(6D):4427-33. PubMed ID: 9494545
[TBL] [Abstract][Full Text] [Related]
15. Lead Time to Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Patients With Low-Risk HPV Oropharynx Cancer.
Califano J; Yousef A; Mostafa H; Valsamakis A; Zhang X; Batis N; Varghese C; Parish J; Forman M; Jarrett J; Messer K; Mehanna H
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):812-819. PubMed ID: 37498566
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
[TBL] [Abstract][Full Text] [Related]
17. Detection of human papillomavirus in squamous cell carcinoma of conjunctiva by nested PCR: a case control study in Iran.
Asadi-Amoli F; Heidari AB; Jahanzad I; Jabbarvand M
Acta Med Iran; 2011; 49(11):707-14. PubMed ID: 22131239
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
